Gene · 64005
Papers2,247
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,247
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Quantitative regulation of the thermal stability of enveloped virus vaccines by surface charge engineering to prevent the self-aggregation of attachment glycoproteins. | PLoS Pathog | 2022 | 35679257 | PubTator, text mining | PubMed |
| Prenatal Maternal Smoke, DNA Methylation, and Multi-omics of Tissues and Child Health. | Curr Environ Health Rep | 2022 | 35670920 | PubTator, text mining | PubMed |
| Adaptation of the H7N2 Feline Influenza Virus to Human Respiratory Cell Culture. | Viruses | 2022 | 35632832 | PubTator, text mining | PubMed |
| Redesigning of Cell-Penetrating Peptides to Improve Their Efficacy as a Drug Delivery System. | Pharmaceutics | 2022 | 35631493 | PubTator, text mining | PubMed |
| Molecular Epidemiology and Evolutionary Dynamics of Human Influenza Type-A Viruses in Africa: A Systematic Review. | Microorganisms | 2022 | 35630344 | PubTator, text mining | PubMed |
Haemagglutinin substitutions N125D, D127E, D222G and R223Q improve replicative fitness and vaccine effectiveness of an A/H1N1pdm09 live attenuated influenza vaccine virus by enhancing α-2,6 receptor binding. | PLoS Pathog | 2022 | 35622874 | PubTator, text mining | PubMed |
| Identification of novel natural inhibitors targeting AKT Serine/Threonine Kinase 1 (AKT1) by computational study. | Bioengineered | 2022 | 35603567 | PubTator, text mining | PubMed |
| Engineering γδ T Cells: Recognizing and Activating on Their Own Way. | Front Immunol | 2022 | 35603176 | PubTator, text mining | PubMed |
| Passive antifouling and active self-disinfecting antiviral surfaces. | Chem Eng J | 2022 | 35601363 | PubTator, text mining | PubMed |
| Influenza chimeric hemagglutinin structures in complex with broadly protective antibodies to the stem and trimer interface. | Proc Natl Acad Sci U S A | 2022 | 35594401 | PubTator, text mining | PubMed |
| Importance of Influenza Anti-Hemagglutinin Antibodies During the SARS-CoV-2 Pandemic in the 2019/2020 Epidemic Season in Poland. | Med Sci Monit | 2022 | 35591768 | PubTator, text mining | PubMed |
| Unique binding pattern for a lineage of human antibodies with broad reactivity against influenza A virus. | Nat Commun | 2022 | 35501328 | PubTator, text mining | PubMed |
| Cryo-EM structures show the mechanistic basis of pan-peptidase inhibition by human α2-macroglobulin. | Proc Natl Acad Sci U S A | 2022 | 35500114 | PubTator, text mining | PubMed |
| Structure of an influenza group 2-neutralizing antibody targeting the hemagglutinin stem supersite. | Structure | 2022 | 35489332 | PubTator, text mining | PubMed |
| Designing topical hyaluronic acid technology-Size does matter…. | J Cosmet Dermatol | 2022 | 35486441 | PubTator, text mining | PubMed |
| Comprehensive Landscape of Prognostic Significance and Immune Characteristics of Myosins in Squamous Cell Carcinoma of the Head and Neck. | J Immunol Res | 2022 | 35478939 | PubTator, text mining | PubMed |
| Peptide-based delivery of therapeutics in cancer treatment. | Mater Today Bio | 2022 | 35434595 | PubTator, text mining | PubMed |
| Hyper-Methylated Hub Genes of T-Cell Receptor Signaling Predict a Poor Clinical Outcome in Lung Adenocarcinoma. | J Oncol | 2022 | 35432532 | PubTator, text mining | PubMed |
| Anurans against SARS-CoV-2: A review of the potential antiviral action of anurans cutaneous peptides. | Virus Res | 2022 | 35430319 | PubTator, text mining | PubMed |
| Weighted Gene Coexpression Network Analysis Identifies TBC1D10C as a New Prognostic Biomarker for Breast Cancer. | Anal Cell Pathol (Amst) | 2022 | 35425695 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64005/papers?page=16